Epidemiology and toxicity of pediatric guanfacine exposures

Annals of Pharmacotherapy

Volumn 36, Issue 11, 2002, Pages 1698-1703

  McGrath, Jean C ^a,b   Klein Schwartz, Wendy ^c,d  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^c Maryland Poison Center   (United States)

^d UNIVERSITY OF MARYLAND   (United States)

Author keywords

Guanfacine; Pediatrics; Toxicology

Indexed keywords

ACTIVATED CARBON; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMPHETAMINE; ANTICONVULSIVE AGENT; GUANFACINE; INFUSION FLUID; IPECAC; LAXATIVE; METHYLPHENIDATE; NALOXONE; NEUROLEPTIC AGENT; OXYGEN;

ADOLESCENT; ADULT; ARTICLE; BRADYCARDIA; CAUSE OF DEATH; CHILD; COMA; CONTROLLED STUDY; DROWSINESS; DRUG EXPOSURE; DRUG INTOXICATION; DRUG OVERDOSE; DRUG SURVEILLANCE PROGRAM; FEMALE; HEALTH CARE FACILITY; HUMAN; HYPOTENSION; LETHARGY; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; MIOSIS; POISON CENTER; PRIORITY JOURNAL; SUICIDE ATTEMPT; TOXICITY;

ADOLESCENT; ADRENERGIC ALPHA-AGONISTS; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGIC METHODS; FEMALE; GUANFACINE; HUMANS; INFANT; MALE; MEDICATION ERRORS; POISON CONTROL CENTERS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 0036840292     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1C030     Document Type: Article

References (13)

1. Goldman LS, Genel M, Bezman RJ, Slanetz PJ. Diagnosis and treatment of attention deficit/hyperactivity disorder in children and adolescents. JAMA 1998:279:1100-7.
2. Silver LB. Alternative (nonstimulant) medications in the treatment of attention deficit hyperactivity disorder in children. Pediatr Clin North Am 1999;45:965-75.
3. Jensen PS, Bhatara VS, Vitiello B, Hoagwood K, Feil M, Burke LB. Psychoactive medication prescribing practices for US children: Gaps between research and clinical practice. J Am Acad Child Adolesc Psychiatry 1999;38:557-65.
4. Hunt RD, Minderaa RB, Cohen DJ. Clonidine benefits children with attention deficit disorder and hyperactivity: Report of a double-blind placebo-controlled crossover study. J Am Acad Child Psychiatry 1985;24: 617-29.
5. Hunt RD. Attention deficit disorder: diagnosis, assessment and treatment. In: Kestenbaum C, Williams D, eds. Handbook of Clinical Assessment of Children and Adolescents: A Biopsychosocial Approach. Vol. 2. New York: New York University Press, 1988:519-61.
6. Hunt RD, Arnsten A, Asbell M. An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1995;34:50-4.
7. Litovitz TL. Klein-Schwartz W. Caravti EM, Youniss J, Crouch B, Lee S. 1998 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 1999; 17:435-87.
8. Tenex. In: Physician’s Desk Reference. Richmond. VA: AH Robins, October 2000.
9. Newcorn JH, Schulz K, Harrison M, Udarbe JK, Halperin JM. Alpha 2 adrenergic agonists. Neurochemistry. Efficacy, and clinical guidelines for use in children. Pediatr Clin North Am 1998;45:1099-122.
10. Van Dyke M, Bonace A. Guanfacine overdose in a pediatric patient. Vet Hum Tox 1990;32:46-7.
11. Cantwell DP. Attention deficit disorder: A review of the past 10 years. J Am Acad Child Adolesc Psychiatry 1996:35:978-87.
12. Zito J, Safer DJ, DosReis S, Gardner JF, Boles M, Lynch F. Trends in the prescribing of psychotropic medications to preschoolers. JAMA 2000; 283:1025-30.
13. Guanfacine. In: Toll LL, Hurlbut KM, eds. Poisondex System. Greenwood Village, CO: MICROMEDEX (expired 6/2002).